170 related articles for article (PubMed ID: 7956947)
81. Effect of castration on extracellular matrix remodeling and angiogenesis of the prostate gland.
Shidaifat F; Gharaibeh M; Bani-Ismail Z
Endocr J; 2007 Aug; 54(4):521-9. PubMed ID: 17527004
[TBL] [Abstract][Full Text] [Related]
82. [Immunohistochemical study of collagen in gastric cancer tissue].
Kondou S; Kanayama K; Morise K
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Apr; 18(2):168-77. PubMed ID: 7553051
[TBL] [Abstract][Full Text] [Related]
83. The expression and localisation of beta-nerve growth factor (beta-NGF) in benign and malignant human prostate tissue: relationship to neuroendocrine differentiation.
Paul AB; Grant ES; Habib FK
Br J Cancer; 1996 Dec; 74(12):1990-6. PubMed ID: 8980402
[TBL] [Abstract][Full Text] [Related]
84. Secretion of transforming growth factor-beta by the immature rat prostate.
Atfi A; Samperez S; Jouan P
Prostate; 1994; 24(3):149-55. PubMed ID: 8115280
[TBL] [Abstract][Full Text] [Related]
85. Transforming growth factor beta 1 as a prognostic factor in pulmonary adenocarcinoma.
Takanami I; Imamura T; Hashizume T; Kikuchi K; Yamamoto Y; Kodaira S
J Clin Pathol; 1994 Dec; 47(12):1098-100. PubMed ID: 7876382
[TBL] [Abstract][Full Text] [Related]
86. Differential oxygen dynamics in two diverse Dunning prostate R3327 rat tumor sublines (MAT-Lu and HI) with respect to growth and respiratory challenge.
Zhao D; Constantinescu A; Hahn EW; Mason RP
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):744-56. PubMed ID: 12062621
[TBL] [Abstract][Full Text] [Related]
87. TGF-beta behavior in the progressive process in the focal glomerulosclerosis rat model: the role of latent TGF-beta-binding protein.
Okuda S; Tamaki K; Ando T; Yanagida T; Fujishima M
Contrib Nephrol; 1996; 118():78-85. PubMed ID: 8744043
[No Abstract] [Full Text] [Related]
88. Adaptive (TINT) Changes in the Tumor Bearing Organ Are Related to Prostate Tumor Size and Aggressiveness.
Adamo HH; Strömvall K; Nilsson M; Halin Bergström S; Bergh A
PLoS One; 2015; 10(11):e0141601. PubMed ID: 26536349
[TBL] [Abstract][Full Text] [Related]
89. Role for stromal heterogeneity in prostate tumorigenesis.
Kiskowski MA; Jackson RS; Banerjee J; Li X; Kang M; Iturregui JM; Franco OE; Hayward SW; Bhowmick NA
Cancer Res; 2011 May; 71(10):3459-70. PubMed ID: 21444670
[TBL] [Abstract][Full Text] [Related]
90. The relationship between the immunodetection of transforming growth factor-beta in lung adenocarcinoma and longer survival rates.
Inoue T; Ishida T; Takenoyama M; Sugio K; Sugimachi K
Surg Oncol; 1995 Feb; 4(1):51-7. PubMed ID: 7780613
[TBL] [Abstract][Full Text] [Related]
91. Prediction of metastatic potential by cancer cell motility in the Dunning R-3327 prostatic adenocarcinoma in vivo model.
Doyle GM; Sharief Y; Mohler JL
J Urol; 1992 Feb; 147(2):514-8. PubMed ID: 1732634
[TBL] [Abstract][Full Text] [Related]
92. Characterization of the heterogeneity of R3327 rat prostatic tumors derived from single-cell clones.
Thompson SA; Johnson MP; Heidger PM; Lubaroff DM
Prostate; 1985; 6(4):369-87. PubMed ID: 4088951
[TBL] [Abstract][Full Text] [Related]
93. Role of transforming growth factor-beta in chronic lymphocytic leukemia.
Israels LG; Israels SJ; Begleiter A; Verburg L; Schwartz L; Mowat MR; Johnston JB
Leuk Res; 1993 Jan; 17(1):81-7. PubMed ID: 8429683
[TBL] [Abstract][Full Text] [Related]
94. Detection of candidates for cancer cell motility inhibitory protein in the Dunning adenocarcinoma model.
Mohler JL; Bakewell WE; Sharief Y; Coleman WB; Chay CH; Silvers SM; Smith GJ
Clin Exp Metastasis; 1995 Nov; 13(6):474-80. PubMed ID: 7586805
[TBL] [Abstract][Full Text] [Related]
95. Thymosin beta 15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer.
Bao L; Loda M; Janmey PA; Stewart R; Anand-Apte B; Zetter BR
Nat Med; 1996 Dec; 2(12):1322-8. PubMed ID: 8946830
[TBL] [Abstract][Full Text] [Related]
96. Evaluation of a fluorinated 2-nitroimidazole binding to hypoxic cells in tumor-bearing rats by 19F magnetic resonance spectroscopy and immunohistochemistry.
Kwock L; Gill M; McMurry HL; Beckman W; Raleigh JA; Joseph AP
Radiat Res; 1992 Jan; 129(1):71-8. PubMed ID: 1728059
[TBL] [Abstract][Full Text] [Related]
97. Time lapse videomicroscopic identification of Dunning R-3327 adenocarcinoma and normal rat prostate cells.
Mohler JL; Partin AW; Isaacs WB; Coffey DS
J Urol; 1987 Mar; 137(3):544-7. PubMed ID: 3820394
[TBL] [Abstract][Full Text] [Related]
98. A common set of nuclear matrix proteins in prostate cancer cells.
Pienta KJ; Lehr JE
Prostate; 1993; 23(1):61-7. PubMed ID: 8337186
[TBL] [Abstract][Full Text] [Related]
99. Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivo.
Oltean S; Febbo PG; Garcia-Blanco MA
Clin Exp Metastasis; 2008; 25(6):611-9. PubMed ID: 18523850
[TBL] [Abstract][Full Text] [Related]
100. Development of an in vitro clonogenic assay for the R3327 rat prostatic adenocarcinoma permits comparison of the proliferative potential of the R3327, R3327A, and R3327AT tumors.
Dibner JJ; Nakeff A
Prostate; 1983; 4(3):289-306. PubMed ID: 6844160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
